Pine Valley Investments Ltd Liability Co
Position in BMY — Bristol Myers Squibb Co
CIK 1975417
MARLTON, NJ
Position in BMY
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$2,478,293
-$64,336 QoQ
Shares Held
43,011
+2.6% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#745
of 2,506 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Derivatives in BMY
reported options exposure · as of Mar 31, 2025CallValue
$6,099
CallShares
100
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Pine Valley Investments Ltd Liability Co holds $80,398,401 across 12 Drug Manufacturers - General names. BMY ranks #6 (3.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
116,193 | $29,509,536 | |
| 2 | ABBV |
AbbVie Inc.
|
72,077 | $18,137,456 | |
| 3 | LLY |
ELI LILLY & Co
|
10,622 | $12,740,346 | |
| 4 | MRK |
Merck & Co., Inc.
|
54,242 | $6,970,097 | |
| 5 | PFE |
Pfizer Inc
|
150,761 | $3,630,324 | |
| 6 | BMY |
Bristol Myers Squibb Co
This page
|
43,011 | $2,478,293 | |
| 7 | NVO |
Novo Nordisk A S
|
48,469 | $2,323,603 | |
| 8 | AMGN |
Amgen Inc
|
4,490 | $1,625,918 |
All Filings in BMY
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,478,293 | 43,011 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $2,542,629 | 41,923 | Shares | Sole | 2026-06-08 | |
| 2025-12-31 | $2,262,135 | 41,938 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,941,464 | 43,048 | Shares | Sole | 2026-02-17 | |
| 2025-06-30 | $2,020,651 | 43,652 | Shares | Sole | 2026-02-17 | |
| 2025-03-31 | $6,099 | 100 | Call | Sole | 2026-02-17 | |
| 2025-03-31 | $2,586,646 | 42,411 | Shares | Sole | 2026-02-17 | |
| 2024-12-31 | $2,531,795 | 44,763 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $2,322,970 | 44,897 | Shares | Sole | 2024-11-25 | |
| 2024-06-30 | $1,840,692 | 44,322 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $2,358,733 | 43,495 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $2,349,792 | 45,796 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,767,231 | 47,678 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $2,736,420 | 42,790 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $460,218 | 6,640 | Shares | Sole | 2023-05-15 | |
| No filing history on record for this holder in this stock. | ||||||